The nanoB2A Group

The nanoB2A Group focuses on the development of photonic and nanomechanical nanobiosensor devices of high sensitivity for label-free detection; biofunctionalization of surfaces; and the integration in lab-on-a-chip microsystems for real field diagnostics applications.

What We Do

We develop biosensors based on plasmonics, evanescent wave sensing and on nanomechanical changes, with high sensitivity and selectivity.

Bioanalytical Aplications

The Bioanalytical Applications research activities cover the detection of a wide range of molecules, of high interest in diverse fields as clinical diagnostic, environmental control, genomic and proteomic, under laboratory and real conditions and using the biosensor devices developed within the Group.

Early Detection of Diseases and Pathogens

Integration of multibiosensor arrays on Lab-on-a-chip platforms will allow the early detection of diseases and pathogens (in vitro and in-vivo).

Lab Gallery

Lab Gallery

Setup Gallery

Setup Gallery

Devices Gallery

DevicesGallery

News

All-optical phase modulation for advanced integrated interferometric point of care biosensors

Desarrollo de un sistema biosensor optomecánico basado en cantilevers

RAIS: Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis

Entidad financiadora: UE. H2020-ICT-2014-1-644956 Duración, desde: 01/01/2015 – 01/01/2018

BRAAVOO: Biosensors, Reporters and Algal Autonomous Vessels for Ocean Operation

Entidad financiadora: UE. FP7-OCEAN-201-614010 Duración: 01/12/2013 – 01/12/2016